{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:54:26Z","timestamp":1791500066529,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.critrevonc.2026.105631","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:14:06Z","timestamp":1790810046000},"page":"105631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From dysbiosis to precision supportive care: the gut microbiota\u2013immune axis in pediatric acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"228","author":[{"given":"Di","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105631_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali","year":"2022","journal-title":"Adv. Cancer Res."},{"issue":"27","key":"10.1016\/j.critrevonc.2026.105631_bib2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2174\/0113816128411949250909113034","article-title":"Para-probiotics as novel anti-inflammatory agents: insight into health benefits and therapeutic applications","volume":"32","author":"Ashique","year":"2026","journal-title":"Curr. Pharm. Des."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105631_bib3","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/sim.6128","article-title":"Instrumental variable methods for causal inference","volume":"33","author":"Baiocchi","year":"2014","journal-title":"Stat. Med."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105631_bib4","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1039\/D2FO02300H","article-title":"Hypoglycemic effect of the polysaccharides from Astragalus membranaceus on type 2 diabetic mice based on the \u201cgut microbiota\u2013mucosal barrier","volume":"13","author":"Chen","year":"2022","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12885-020-6654-5","article-title":"Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy","volume":"20","author":"Chua","year":"2020","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105631_bib6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/ijc.32942","article-title":"Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota","volume":"147","author":"De Pietri","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105631_bib7","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cmet.2025.12.017","article-title":"Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis","volume":"38","author":"Ding","year":"2026","journal-title":"Cell. Metab."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105631_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41577-023-00874-w","article-title":"Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease","volume":"23","author":"Donald","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2023.102745","article-title":"Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil","volume":"27","author":"Dufrayer","year":"2023","journal-title":"Braz. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105631_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30328","article-title":"The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: a double-blind randomized clinical trial","volume":"70","author":"Eghbali","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib12","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/INF.0000000000000591","article-title":"Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia","volume":"34","author":"Felsenstein","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.critrevonc.2026.105631_bib13","article-title":"Fecal microbiota transplantation promotes gut microbiome recovery in pediatric hematopoietic stem cell transplant recipients","volume":"5","author":"Fernandez","year":"2026","journal-title":"Front. Micro"},{"issue":"7480","key":"10.1016\/j.critrevonc.2026.105631_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/2643-3230.BCD-22-0172","article-title":"Microbiota influences on hematopoiesis and blood cancers: new horizons?","volume":"4","author":"Galloway-Pe\u00f1a","year":"2023","journal-title":"Blood Cancer Discov."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1078-0432.CCR-25-1676","article-title":"The potential of the gut microbiota and butyrate to enhance CAR T-cell therapy in non-Hodgkin lymphoma","volume":"32","author":"Garc\u00eda-Vicente","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105631_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1017\/ice.2021.515","article-title":"Lactobacillus bloodstream infections genetically related to probiotic use in pediatric hematopoietic cell transplant patients","volume":"44","author":"Gilliam","year":"2023","journal-title":"Infect. Control. Hosp. Epidemiol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105631_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism for childhood acute lymphoblastic leukaemia","volume":"18","author":"Greaves","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105631_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41591-024-02823-z","article-title":"A gut microbial signature for combination immune checkpoint blockade across cancer types","volume":"30","author":"Gunjur","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2229567","article-title":"Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward","volume":"15","author":"Habibi","year":"2023","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib21","doi-asserted-by":"crossref","first-page":"G601","DOI":"10.1152\/ajpgi.00316.2020","article-title":"The role of butyrate in surgical and oncological outcomes in colorectal cancer","volume":"320","author":"Hajjar","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/ciy153","article-title":"Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia","volume":"67","author":"Hakim","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12967-023-04091-w","article-title":"Intestinal barrier functions in hematologic and oncologic diseases","volume":"21","author":"Haroun","year":"2023","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/cancers16040723","article-title":"Treatment of pediatric acute lymphoblastic leukemia: a historical perspective","volume":"16","author":"Hayashi","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105631_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/ejh.70121","article-title":"Microbiome-based modeling of CAR-T therapy response in lymphoma: insights from shotgun metagenomics sequencing","volume":"116","author":"Hernani","year":"2026","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44276-023-00008-8","article-title":"Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle","volume":"1","author":"Hes","year":"2023","journal-title":"BJC Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105631_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz8405","article-title":"12R-HETE acts as an endogenous ligand for Nur77 in the intestines and regulates NKp46+ ILC3 development","volume":"12","author":"Huang","year":"2026","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105631_bib28","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/cncr.28688","article-title":"Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia","volume":"120","author":"Inaba","year":"2014","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105631_bib29","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s40168-019-0745-z","article-title":"Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ingham","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.critrevonc.2026.105631_bib31","isbn-type":"print","article-title":"JBI Manual for Evidence Synthesis","author":"Aromataris","year":"2024","ISBN":"https:\/\/id.crossref.org\/isbn\/9780648848820"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.chembiol.2024.12.005","article-title":"Metabolic tug-of-war: microbial metabolism shapes colonization resistance against enteric pathogens","volume":"32","author":"Jones","year":"2025","journal-title":"Cell. Chem. Biol."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105631_bib33","doi-asserted-by":"crossref","first-page":"12323","DOI":"10.3390\/ijms241512323","article-title":"Significance of Th17 and Treg in treatment efficacy and outcome in pediatric acute lymphoblastic leukemia","volume":"24","author":"Kr\u0119towska-Grunwald","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105631_bib35","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/s41390-022-02104-w","article-title":"Impact of antibiotics on off-target infant gut microbiota and resistance genes in cohort studies","volume":"92","author":"Lebeaux","year":"2022","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.critrevonc.2026.105631_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.880484","article-title":"Roles of secretory immunoglobulin A in host-microbiota interactions in the gut ecosystem","volume":"13","author":"Le\u00f3n","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105631_bib37","article-title":"Extremophyte-derived exosome-like nanovesicles remodel intestinal barrier dysfunction by multi-dimensional intervention: physical barrier repair with immune homeostasis and microbiome regulation","author":"Li","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-025-00789-x","article-title":"A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders","volume":"11","author":"Li","year":"2025","journal-title":"Cell. Discov."},{"issue":"36","key":"10.1016\/j.critrevonc.2026.105631_bib39","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1021\/acs.jafc.2c03091","article-title":"Study on the effect of molecular weight on the gut microbiota fermentation properties of blackberry polysaccharides in vitro","volume":"70","author":"Li","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105631_bib40","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1007\/s10787-025-02044-x","article-title":"Gut microbiome-targeted therapeutics for chronic kidney disease: comparative efficacy of probiotic and microbial preparations","volume":"33","author":"Li","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41588-021-00968-y","article-title":"Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome","volume":"54","author":"Liu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2026.105631_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.558799","article-title":"Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105631_bib43","doi-asserted-by":"crossref","DOI":"10.1200\/GO.21.00266","article-title":"Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage","author":"Major","year":"2022","journal-title":"JCO Glob. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105631_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jiad190","article-title":"Microbiota predict infections and acute graft-versus-host disease after pediatric allogeneic hematopoietic stem cell transplantation","volume":"228","author":"Margolis","year":"2023","journal-title":"J. Infect. Dis."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105631_bib45","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.2023020026","article-title":"Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children","volume":"142","author":"Masetti","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ijms21020379","article-title":"Recent advances in lipopolysaccharide recognition systems","volume":"21","author":"Mazgaeen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1870402","article-title":"Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis","volume":"13","author":"McDonnell","year":"2021","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00161-21","article-title":"Fecal microbiota transplantation donor screening updates and research gaps for solid organ transplant recipients","volume":"60","author":"Mehta","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105631_bib49","unstructured":"National Cancer Institute, 2026. Organization of the NCTN. https:\/\/dctd.cancer.gov\/research\/networks\/nctn\/organization (accessed 12 September 2026)."},{"key":"10.1016\/j.critrevonc.2026.105631_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2026.1791192","article-title":"Distinct effects of a dairy probiotic drink and physical exercise on gut microbiota in pediatric acute lymphoblastic leukemia patients in remission: a randomized clinical trial","volume":"17","author":"Nechalov\u00e1","year":"2026","journal-title":"Front. Microbiol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105631_bib51","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.3390\/cancers13194947","article-title":"The microbiome in childhood acute lymphoblastic leukemia","volume":"13","author":"Oldenburg","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41523-024-00707-6","article-title":"Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer","volume":"10","author":"Otto-Dobos","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105631_bib53","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ 372"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105631_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41568-023-00584-4","article-title":"Gut microbiome immaturity and childhood acute lymphoblastic leukaemia","volume":"23","author":"Peppas","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib55","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105631_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cmi.2016.11.001","article-title":"Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial","volume":"23","author":"Santolaya","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12098-023-04635-4","article-title":"Relapsed acute lymphoblastic leukemia","volume":"91","author":"Sidhu","year":"2024","journal-title":"Indian. J. Pediatr."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib58","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","article-title":"Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy","volume":"28","author":"Smith","year":"2022","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105631_bib59","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/bloodadvances.2024013986","article-title":"Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia","volume":"9","author":"S\u00f8rum","year":"2025","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105631_bib60","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","article-title":"A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy","volume":"29","author":"Stein-Thoeringer","year":"2023","journal-title":"Nat. Med."},{"issue":"7728","key":"10.1016\/j.critrevonc.2026.105631_bib61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","article-title":"Temporal development of the gut microbiome in early childhood from the TEDDY study","volume":"562","author":"Stewart","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105631_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127743","article-title":"Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity","volume":"14","author":"Su","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/0127724328332998250118182255","article-title":"The gut connection: a narrative review on the in-depth analysis of gut microbiota and metabolites in depression","volume":"21","author":"Sultana","year":"2026","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105631_bib64","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/nu18101590","article-title":"Effects of high-inorganic-phosphorus diet on intestinal mucosal injury and immune alteration in mice","volume":"18","author":"Sun","year":"2026","journal-title":"Nutrients"},{"issue":"7758","key":"10.1016\/j.critrevonc.2026.105631_bib65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","article-title":"The Integrative Human Microbiome Project","volume":"569","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/discim\/kyaf020","article-title":"Striking a balance: how the gut microbiome shapes the fate of intestinal CD4+ T cells","volume":"5","author":"Till","year":"2026","journal-title":"Discov. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09522-3","volume":"22","author":"Toksvang","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105631_bib68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41416-025-02958-x","article-title":"ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study","volume":"132","author":"Trinquand","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.32120","article-title":"Infectious complications during early treatment of childhood acute lymphoblastic leukemia-a comparison between the ALLTogether and NOPHO ALL-2008 protocols","volume":"73","author":"van Bunningen","year":"2026","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105631_bib70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/599346","article-title":"Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut","volume":"49","author":"van Vliet","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105631_bib71","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2352-4642(26)00039-8","article-title":"Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial","volume":"10","author":"Vissing","year":"2026","journal-title":"Lancet Child. Adolesc. Health"},{"key":"10.1016\/j.critrevonc.2026.105631_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078093","article-title":"Reading and conducting instrumental variable studies: guide, glossary, and checklist","volume":"387","author":"Walker","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12941-024-00717-z","article-title":"Microbial metagenomic shifts in children with acute lymphoblastic leukaemia during induction therapy and predictive biomarkers for infection","volume":"23","author":"Wang","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijc.35136","article-title":"Intestinal mucositis, systemic inflammation and bloodstream infections following high-dose methotrexate treatment in childhood acute lymphoblastic leukaemia: comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol","volume":"156","author":"Weischendorff","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105631_bib75","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fmicb.2019.01300","article-title":"Interactions between gut microbiota and acute childhood leukemia","volume":"10","author":"Wen","year":"2019","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105631_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154944","article-title":"Next-generation sequencing: insights to advance clinical investigations of the microbiome","volume":"132","author":"Wensel","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105631_bib78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08880018.2016.1276235","article-title":"Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia","volume":"34","author":"Yeoh","year":"2017","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105631_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116378","article-title":"Remodeling the gut ecosystem and its mechanism: natural products in the treatment of ulcerative colitis via regulating gut microbiota and metabolites","volume":"174","author":"Zhang","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105631_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114985","article-title":"Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: a review","volume":"164","author":"Zhao","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105631_bib81","article-title":"NLRP3 inflammasome promotes the progression of acute myeloid leukemia via IL-1\u03b2 pathway","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:46:22Z","timestamp":1791499582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":81,"alternative-id":["S1040842826005184"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105631","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From dysbiosis to precision supportive care: the gut microbiota\u2013immune axis in pediatric acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105631"}}